Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Druggability Technologies Appoints Louis Scotti as Chief Business Development Officer

Abstract:
Druggability Technologies Holdings Limited (DRGT), a privately held biotechnology platform company, today announced the appointment of Louis Scotti to the newly created position of Chief Business Development Officer. Mr. Scotti will be responsible for all business development activities and managing the company's numerous existing collaborations for its NanoActive™ technology platform, which significantly improves the solubility, permeability and pharmacokinetics of diverse chemical and biological compounds.

Druggability Technologies Appoints Louis Scotti as Chief Business Development Officer

Dublin, Ireland | Posted on August 3rd, 2012

"We are pleased that Mr. Scotti has joined our senior management team at DRGT," said Gabor Heltovics, CEO of DRGT. "With his long track record of concluding major drug development collaborations with pharmaceutical and biotechnology companies worldwide, Mr. Scotti will be an integral part of our efforts to expand the successful application of our proprietary technologies."

Mr. Scotti most recently served in senior commercial roles during a 12-year career at Arena Pharmaceuticals, Inc., a NASDAQ listed company that recently received FDA approval of Belviq® (lorcaserin HCl), the first prescription weight-loss treatment approved by FDA in 13 years. At Arena, Mr. Scotti held several positions, including Vice President Business Development, Vice President Marketing & Business Development and Vice President Commercial Planning. He was directly responsible for corporate alliances with major pharmaceutical companies such as Merck, J&J and Eli Lilly. Previously, Mr. Scotti was CEO of ProtoMed, Inc. and earlier headed licensing activities as executive director for Ligand Pharmaceuticals, Inc. Mr. Scotti holds a B.S.E. in biomedical engineering from the University of Pennsylvania.

####

About Druggability Technologies Holdings Limited (DRGT)
Headquartered in Dublin, Ireland, DRGT, through its subsidiaries, is developing and commercializing its proprietary NanoActive™ high throughput technology platform. This platform delivers significant improvements in compound solubility, permeability and pharmacokinetics that can be applied across a diverse universe of chemical and biological compounds.

The Company's experience in improving the bioavailability and kinetic profile of drugs is born of a heritage of three decades of scientific and industrial knowledge gained through successful commercial ventures in bio- and chemo-informatics, combinatorial chemistry, chemical genomics, flow chemistry, colloidal chemistry, and nanotechnology.

For more information, please click here

Contacts:
Druggability Technologies Holdings Ltd.
Gabor Heltovics
Chief Executive Officer
+36-1-8808-468
+36-1-8808-501 (FAX)

Copyright © Marketwire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Scientists reveal breakthrough in optical fiber communications December 21st, 2014

Atom-thick CCD could capture images: Rice University scientists develop two-dimensional, light-sensitive material December 20th, 2014

Oregon researchers glimpse pathway of sunlight to electricity: Collaboration with Lund University uses modified UO spectroscopy equipment to study 'maze' of connections in photoactive quantum dots December 19th, 2014

Instant-start computers possible with new breakthrough December 19th, 2014

Nanomedicine

Creation of 'Rocker' protein opens way for new smart molecules in medicine, other fields December 18th, 2014

Iranian Researchers Produce Electrical Pieces Usable in Human Body December 18th, 2014

Unraveling the light of fireflies December 17th, 2014

First Home-Made Edible Herbal Nanodrug Presented to Pharmacies across Iran December 17th, 2014

Announcements

Scientists reveal breakthrough in optical fiber communications December 21st, 2014

Atom-thick CCD could capture images: Rice University scientists develop two-dimensional, light-sensitive material December 20th, 2014

Oregon researchers glimpse pathway of sunlight to electricity: Collaboration with Lund University uses modified UO spectroscopy equipment to study 'maze' of connections in photoactive quantum dots December 19th, 2014

Instant-start computers possible with new breakthrough December 19th, 2014

Appointments/Promotions/New hires/Resignations/Deaths

Aculon Hires New Business Development Director December 19th, 2014

Nanomedicine expert joins Rice faculty: Gang Bao combines genetic, nano and imaging techniques to fight disease December 17th, 2014

Nexeon Attracts ex-Nokia Product Executive to its Board of Directors December 15th, 2014

Arrowhead Appoints Patrick O'Brien as General Counsel December 4th, 2014

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE